We are live on ! Find out more
MYGN icon

Myriad Genetics
MYGN

190 hedge funds and large institutions have $1.91B invested in Myriad Genetics in 2023 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 61 increasing their positions, 75 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

24,360% more call options, than puts

Call options by funds: $17.1M | Put options by funds: $70K

69% more capital invested

Capital invested by funds: $1.13B → $1.91B (+$778M)

1.75% more ownership

Funds ownership: 99.52% → 101.27% (+1.8%)

4% less funds holding

Funds holding: 197 → 190 (-7)

18% less first-time investments, than exits

New positions opened: 23 | Existing positions closed: 28

19% less repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 75

Holders
190
Holders Change
-7
Holders Change %
-3.55%
% of All Funds
3.03%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
23
Increased
61
Reduced
75
Closed
28
Calls
$17.1M
Puts
$70K
Net Calls
+$17.1M
Net Calls Change
+$15.8M

Top Buyers

1
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$32.3M
2
GCM
Glenview Capital Management
New York
+$22.3M
3
Bank of America
Bank of America
North Carolina
+$15.9M
4
PAMS
Pictet Asset Management (Switzerland)
Switzerland
+$11.6M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$2.79M

Top Sellers

1
State Street
State Street
Massachusetts
-$8.48M
2
Invesco
Invesco
Georgia
-$7.81M
3
Morgan Stanley
Morgan Stanley
New York
-$5.51M
4
EARNEST Partners
EARNEST Partners
Georgia
-$4.95M
5
BlackRock
BlackRock
New York
-$4.64M
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$328M -$4.64M -228,391 -2%
Vanguard Group
2
Vanguard Group
Pennsylvania
$216M -$271K -13,347 -0.1%
CCM
3
Camber Capital Management
Massachusetts
$163M – – –
Wellington Management Group
4
Wellington Management Group
Massachusetts
$156M -$1.15M -56,384 -0.8%
State Street
5
State Street
Massachusetts
$107M -$8.48M -417,504 -8%
GCM
6
Glenview Capital Management
New York
$97.5M +$22.3M +1,097,344 +35%
Bank of America
7
Bank of America
North Carolina
$79.7M +$15.9M +783,718 +30%
EARNEST Partners
8
EARNEST Partners
Georgia
$71.1M -$4.95M -243,618 -7%
Dimensional Fund Advisors
9
Dimensional Fund Advisors
Texas
$63.3M +$1.84M +90,532 +3%
Artisan Partners
10
Artisan Partners
Wisconsin
$51.3M -$234K -11,499 -0.5%
DGI
11
Disciplined Growth Investors
Minnesota
$48.5M -$3.73M -183,660 -8%
D.E. Shaw & Co
12
D.E. Shaw & Co
New York
$46M +$2.54M +125,025 +7%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$37.3M +$1.59M +78,333 +5%
Balyasny Asset Management
14
Balyasny Asset Management
Illinois
$36.9M +$32.3M +1,588,977 New
Millennium Management
15
Millennium Management
New York
$32.2M -$1.77M -87,025 -6%
Goldman Sachs
16
Goldman Sachs
New York
$32.1M -$187K -9,209 -0.7%
SEI Investments
17
SEI Investments
Pennsylvania
$30.2M +$1.74M +85,662 +7%
Northern Trust
18
Northern Trust
Illinois
$23.2M -$247K -12,161 -1%
PAMS
19
Pictet Asset Management (Switzerland)
Switzerland
$20.3M +$11.6M +572,778 +191%
Charles Schwab
20
Charles Schwab
California
$20.2M +$611K +30,084 +4%
Bank of New York Mellon
21
Bank of New York Mellon
New York
$17.6M -$1.08M -53,310 -7%
Morgan Stanley
22
Morgan Stanley
New York
$14.5M -$5.51M -271,479 -30%
Principal Financial Group
23
Principal Financial Group
Iowa
$11.6M -$123K -6,046 -1%
State Farm Mutual Automobile Insurance
24
State Farm Mutual Automobile Insurance
Illinois
$10.4M – – –
Invesco
25
Invesco
Georgia
$9.83M -$7.81M -384,570 -48%
1
2 3 4 5

MYGN Hedge Fund Activity: Q1 2023 in Review

190 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Myriad Genetics (MYGN) for Q1 2023, worth a combined $1.91B — up 69% from $1.13B a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of MYGN and 23 opened new positions — a net loss of 5 holders — while 75 trimmed existing stakes and 61 added.

The largest buyer was Balyasny Asset Management, opening a new position worth an estimated $32.3M. The largest seller was State Street, cutting an estimated $8.48M.

  • 190 institutional investors held Myriad Genetics (MYGN) as of Q1 2023, down from 197 in Q4 2022.
  • Funds reported $1.91B of Myriad Genetics stock for Q1 2023, up 69% quarter-over-quarter.
  • 23 funds opened new Myriad Genetics positions in Q1 2023 and 28 closed out, a net change of -5 holders.
  • The largest Myriad Genetics buyer in Q1 2023 was Balyasny Asset Management, an estimated $32.3M added.
  • The largest Myriad Genetics seller in Q1 2023 was State Street, an estimated $8.48M sold.

Based on aggregated 13F filings for Q1 2023.